Brief: Xilio Therapeutics Q2 Net Income USD -13.925 Million
08/08/2024 12:30
Aug 08 (Reuters) - Xilio Therapeutics Q2 basic EPS USD -0.24. * Q2 operating expenses USD 17.061 million * Q2 income from operations USD -14.704 million
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla